A passion for outthinking cancer
Eric, Associate Director at Merrimack
Our collaborations

Innovation doesn’t happen alone.
Learn more about teaming with Merrimack.

Learn more

News

View all news
September 06, 2018

Merrimack Completes Enrollment in Randomized Phase 2 SHERLOC Study of MM-121 (seribantumab) in Non-Small Cell Lung Cancer (NSCLC)

Read more
August 07, 2018

Merrimack Reports Second Quarter 2018 Financial Results

Read more
July 31, 2018

Merrimack Announces Timing of Second Quarter 2018 Investor Conference Call

Read more
July 02, 2018

Merrimack Secures $25 Million Debt Facility with Hercules Capital

Read more

Social Media

Follow us on Twitter

September 18, 2018
@MerrimackPharma
In case you missed our paper in @scisignal, we recently developed a multi-scale computational model that quantitati… http://q2MtdVMRsZ

September 6, 2018
@MerrimackPharma
Today we announced the completion of enrollment in our randomized Phase 2 clinical trial evaluating our lead invest… http://XHBMmt6raq